Eric J. Aulicino, Chief Executive Officer, LifeAire Systems
There is a pattern I have observed in the hospital networks where air quality decisions get made well, and in the ones where they stall. The difference is rarely about the data. The peer-reviewed evidence is available to everyone. The financial case can be calculated from publicly available benchmarks. The technology exists and has been validated in real operational environments.
The difference is almost always about who is in the room when the conversation happens — and whether those people are speaking to each other or past each other.
Air quality sits at the intersection of clinical outcomes, operational performance, and financial planning. That means it is nobody’s sole domain and everybody’s partial concern. The infection preventionist cares about pathogen burden. The facilities director cares about HVAC infrastructure and maintenance burden. The CFO cares about cost per case and CMS penalty exposure. The CNO cares about staff health and retention. The COO cares about throughput and bed utilization.
Each of those people has a legitimate and important stake in the air quality decision. And in most hospital networks, they are not having the conversation together. The result is that air quality gets evaluated through whichever single lens happens to initiate the conversation — usually infection control — and the full case never gets assembled in a room with the authority to act on it.
This post is an attempt to give each of those stakeholders the piece of the picture that belongs to them, so that when they do get in the room together, they are starting from a shared understanding rather than a series of disconnected departmental interests.
WHAT THE CFO NEEDS TO UNDERSTAND
For a CFO, the air quality conversation needs to begin and end with a number that is credible, specific, and traceable to a source.
The most compelling number in LifeAire’s clinical record is the St. Luke’s Allentown outcome: $2.3 million in documented savings in a single year, across 14 protected beds, from a system that cost less than $125,000 fully installed. That result came from a combination of HAI reduction and length of stay reduction documented in a 12-month double-blind study of 8,255 patients, published in the journal Surgery. The data was generated by St. Luke’s, not by LifeAire.
The mechanism behind that result matters for the CFO conversation. Length of stay is the primary financial driver — not HAI reduction, which, while meaningful, addresses a relatively small fraction of the total patient census through the airborne transmission mechanism specifically. Length of stay improvement extends across the whole census. Every patient who recovers faster and goes home earlier frees a bed, improves throughput, and reduces per-case cost. In a system with high occupancy, that translates directly to revenue capacity.
The secondary financial drivers are equally real. In our experience across the facilities we have studied, staff absenteeism in LifeAire-protected environments drops substantially — in one peer-reviewed 15-month study, staff call-outs fell 47%. Agency staffing and overtime costs follow absenteeism closely. Surface cleaning burden decreases as airborne pathogen load decreases, because in our experience a significant proportion of surface contamination originates from airborne deposition — when you reduce what is in the air, you reduce what lands on surfaces. CMS penalty exposure from HAI rates is a line item that responds directly to infection reduction.
For a CFO who wants to stress-test the case conservatively: even a 5% reduction in length of stay — a fraction of what St. Luke’s documented — produces a system payback within two years in most hospital configurations. LifeAire’s ROI framework can be applied to any facility’s own bed count, occupancy rate, average length of stay, and per-diem cost to generate a facility-specific projection. That conversation is one we are willing to have directly with financial leadership.
WHAT THE COO NEEDS TO UNDERSTAND
For a COO, the air quality conversation is fundamentally about operational reliability and throughput capacity.
Bed utilization is the central metric. A hospital that consistently turns beds faster — because patients are recovering more quickly in a cleaner air environment — has more effective capacity without adding a single bed or hiring a single additional staff member. At current occupancy rates in most acute care hospitals, incremental bed availability is not a trivial operational gain. It is the difference between diverting patients and accepting them, between running elective procedures on schedule and backing them up, between meeting community demand and falling short of it.
Staff reliability is the second operational lever. A COO managing a workforce in an environment with high absenteeism rates is constantly solving a resource allocation problem that should not need solving. Shifts covered by agency staff are more expensive, less familiar with the unit, and more likely to introduce process variations that affect outcomes. A 47% reduction in staff call-outs, as documented in our peer-reviewed long-term care study, is not a clinical result — it is an operational result of the first order. It means the schedule holds. It means the team that worked yesterday is the team working today. It means the institutional knowledge and protocol familiarity that reduces errors stays in the building.
Supply chain and environmental services are a third COO consideration. When airborne pathogen load decreases, surface contamination decreases in proportion. In our operational experience, the areas protected by LifeAire technology show substantially fewer surface pathogens than unprotected areas — at St. Luke’s, 80% fewer surface pathogens in protected units based on their ongoing daily ATP swab data. Fewer surface pathogens means less cleaning burden, lower cleaning supply consumption, and reduced turnaround time between patient occupancies. In a high-throughput environment, that margin matters.
Installation and integration deserve a word here too, because a COO will rightly want to understand the operational disruption of adding a new system. LifeAire’s in-duct systems integrate into existing HVAC infrastructure with minimal construction — essentially replacing a section of ductwork. The Aire~IRMU modular unit requires no HVAC modification at all. Neither requires meaningful operational downtime to install. The Aire~Design engineering service works directly alongside facilities and HVAC teams to plan and execute installation in a way that fits around the unit’s operational schedule. Details at lifeaire.com/aire-design.
WHAT THE CNO NEEDS TO UNDERSTAND
For a Chief Nursing Officer, the air quality conversation touches the most personal and immediate concern of all: the health and wellbeing of the nursing staff.
Nurses are the population with the highest continuous exposure to the hospital air environment. They are there for full shifts, often consecutive shifts, in units where the pathogen burden fluctuates with census, acuity, and season. They are also the population whose absenteeism has the most direct and visible operational consequence — because when a nurse calls out, someone else absorbs that shift, morale takes a hit, and the accumulated burden of covering gaps compounds over time into the burnout and turnover that CNOs are managing as a chronic challenge across the industry.
The 47% reduction in staff call-outs documented in our 15-month peer-reviewed study is a number that belongs in the nursing retention and recruitment conversation, not just the infection control conversation. A work environment that demonstrably protects its staff from airborne illness is a work environment that can make a credible claim to caring about the people who work there. That claim has value in recruitment — particularly in a market where nurses have choices and are making decisions based on factors beyond compensation.
Patient outcomes are the CNO’s deepest professional commitment, and the air quality connection to patient outcomes runs through every mechanism this post has described. Faster recovery means shorter stays and better patient experience. Reduced infection rates mean fewer complications and readmissions. Cleaner surfaces mean lower cross-contamination risk during care delivery. Every one of those outcomes is one that nursing leadership is responsible for and accountable to, and every one of them is influenced by the quality of the air in the clinical environment.
The CNO is also often the most credible internal advocate for this conversation at the C-suite level, because they sit at the intersection of clinical authority and operational responsibility. When nursing leadership says that air quality is a patient safety issue and a staff health issue simultaneously, that framing carries weight in a way that a facilities proposal or a financial analysis alone does not.
THE CONVERSATION THAT NEEDS TO HAPPEN
The hospital networks that have moved most decisively on air quality — including St. Luke’s, Jefferson Lehigh Valley Healthcare Network, and others in LifeAire’s installed base — share a common characteristic. The decision was not made by one department. It was made by a leadership team that looked at the same data from three different vantage points, recognized that the case was compelling from all three, and moved together.
That kind of cross-functional alignment does not happen by accident. It requires someone to convene the conversation — to bring the CFO’s financial lens, the COO’s operational lens, and the CNO’s clinical and staffing lens into the same room with the same set of facts. In our experience, infection control leadership is often the initiating voice. But the decision that sticks is the one made by the full leadership team.
If you are an infection control leader reading this and you have been trying to make the air quality case in isolation, this post is an invitation to broaden the conversation. The financial case belongs in front of your CFO. The operational case belongs in front of your COO. The staff health case belongs in front of your CNO. Bring all three, and the conversation changes.
To review the peer-reviewed clinical evidence that supports all three cases, visit lifeaire.com/resources. To understand what the air in your facility currently looks like, start with an Aire~Analysis at lifeaire.com/air-quality-consultation. For the complete guide to air quality as a continuous infection control platform, visit lifeaire.com/air-quality-as-a-continuous-infection-control-platform-lifeaire-systems.
ABOUT THE AUTHOR
Eric J. Aulicino is Chief Executive Officer of LifeAire Systems, leading the company’s global commercial strategy and market expansion across hospital, IVF, life sciences, and long-term care markets. He brings more than three decades of global executive leadership including 25 years of international experience in Europe, China, and India. Full biography: lifeaire.com/eric-aulicino